The price prediction for Viking Therapeutics (VKTX) stock can be analyzed as follows:
- Current Analyst Price Target: The current price target for VKTX, as of April 2, 2024, to May 2, 2024, is $90 with a "Strong Buy" rating from Joseph Pantginis of HC Wainwright & Co. This rating was reiterated on April 25, 20241.
- Average Price Target: Based on 9 Wall Street analysts offering 12-month price targets for VKTX in the last 3 months, the average price target is $113.50, indicating a potential upside of 38.41% from the current price target26.
- Stock Forecast: For the upcoming trading day, the stock is expected to open at $75.84, and during the day, it may move within a range based on the 14-day Average True Range4.
- Long-Term Prediction: The stock prediction for 2025 is currently $104.66, assuming a continued average yearly growth5.
- Market Sentiment: The sentiment around VKTX is bullish, as indicated by the "Strong Buy" consensus and the high estimate of $138 for the average price target63.
In conclusion, the price prediction for VKTX is positive, with an average price target suggesting a significant upside potential from the current levels. The "Strong Buy" rating and bullish sentiment from analysts further support a favorable outlook for the stock.